JP2008513472A5 - - Google Patents

Download PDF

Info

Publication number
JP2008513472A5
JP2008513472A5 JP2007532479A JP2007532479A JP2008513472A5 JP 2008513472 A5 JP2008513472 A5 JP 2008513472A5 JP 2007532479 A JP2007532479 A JP 2007532479A JP 2007532479 A JP2007532479 A JP 2007532479A JP 2008513472 A5 JP2008513472 A5 JP 2008513472A5
Authority
JP
Japan
Prior art keywords
hydrogen
haloalkyl
alkyl
haloalkoxy
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007532479A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008513472A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/033051 external-priority patent/WO2006034004A2/en
Publication of JP2008513472A publication Critical patent/JP2008513472A/ja
Publication of JP2008513472A5 publication Critical patent/JP2008513472A5/ja
Pending legal-status Critical Current

Links

JP2007532479A 2004-09-17 2005-09-16 システインプロテアーゼインヒビターの調製のための方法及び中間体 Pending JP2008513472A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61080604P 2004-09-17 2004-09-17
PCT/US2005/033051 WO2006034004A2 (en) 2004-09-17 2005-09-16 Processes and intermediates for preparing cysteine protease inhibitors

Publications (2)

Publication Number Publication Date
JP2008513472A JP2008513472A (ja) 2008-05-01
JP2008513472A5 true JP2008513472A5 (enExample) 2008-07-03

Family

ID=35899659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007532479A Pending JP2008513472A (ja) 2004-09-17 2005-09-16 システインプロテアーゼインヒビターの調製のための方法及び中間体

Country Status (15)

Country Link
US (1) US7737300B2 (enExample)
EP (1) EP1799645A2 (enExample)
JP (1) JP2008513472A (enExample)
KR (1) KR20070061877A (enExample)
CN (1) CN101068783A (enExample)
AU (1) AU2005287046A1 (enExample)
BR (1) BRPI0515470A (enExample)
CA (1) CA2580065A1 (enExample)
CR (1) CR8993A (enExample)
EC (1) ECSP077321A (enExample)
IL (1) IL181792A0 (enExample)
MX (1) MX2007003118A (enExample)
NO (1) NO20071937L (enExample)
WO (1) WO2006034004A2 (enExample)
ZA (1) ZA200703102B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1663958E (pt) 2003-09-18 2015-06-01 Virobay Inc Compostos contendo haloalquilo como inibidores de protease de cisteína
JP5154944B2 (ja) 2004-12-02 2013-02-27 ビロベイ,インコーポレイティド システインプロテアーゼインヒビターとしてのスルホンアミド含有化合物
DK1865940T3 (da) 2005-03-21 2013-03-04 Virobay Inc Alfaketoamidforbindelser som cysteinproteasehæmmere
CA2602112A1 (en) 2005-03-22 2006-09-28 Celera Genomics Sulfonyl containing compounds as cysteine protease inhibitors
WO2008028301A1 (en) * 2006-09-08 2008-03-13 Merck Frosst Canada Ltd. Prodrugs of inhibitors of cathepsin s
US20100048717A1 (en) 2006-09-25 2010-02-25 MERCK FROSST CANADA LTD, Merk & Co., Inc. Cathepsin b inhibitors
US7893112B2 (en) 2006-10-04 2011-02-22 Virobay, Inc. Di-fluoro containing compounds as cysteine protease inhibitors
DK2079683T3 (en) 2006-10-04 2015-04-27 Virobay Inc Difluoro-containing compounds as cysteine protease inhibitors
EP2099444A4 (en) 2006-12-14 2012-11-07 Nps Pharma Inc USE OF D-SERIN DERIVATIVES FOR THE TREATMENT OF ANTIBODIES
CA2682622A1 (en) * 2007-04-02 2008-10-09 Merck Frosst Canada Ltd. Amidation process for the preparation of cathepsin k inhibitors
WO2010045251A2 (en) 2008-10-17 2010-04-22 Xenon Pharmaceuticals, Inc. Spiro-oxindole compounds and their use as therapeutic agents
EP2445872A4 (en) * 2009-06-22 2012-12-05 Merck Canada Inc CATHEPSIN CYSTEIN PROTEASE FOR THE TREATMENT OF VARIOUS DISEASES
US8324417B2 (en) 2009-08-19 2012-12-04 Virobay, Inc. Process for the preparation of (S)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl esters and acid salts thereof
WO2012119941A1 (en) 2011-03-04 2012-09-13 Prozymex A/S Peptidyl nitrilcompounds as peptidase inhibitors
CN104039151A (zh) * 2011-06-17 2014-09-10 维罗贝股份有限公司 治疗中枢神经系统中小神经胶质细胞介导的神经元缺失的组织蛋白酶抑制剂
EP3342765B1 (en) * 2015-08-29 2021-09-15 Sunshine Lake Pharma Co., Ltd. Cathepsin k inhibitor and application thereof
CN106478564B (zh) * 2015-08-29 2021-11-12 广东东阳光药业有限公司 组织蛋白酶k抑制剂及其用途
WO2020201572A1 (en) 2019-04-05 2020-10-08 Université De Bretagne Occidentale Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ503889A (en) * 1997-11-05 2002-07-26 Novartis Ag Dipeptide nitriles
GB9723407D0 (en) * 1997-11-05 1998-01-07 Ciba Geigy Ag Organic compounds
WO2000049007A1 (en) * 1999-02-20 2000-08-24 Astrazeneca Ab Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
EP1434769A2 (en) * 2001-10-02 2004-07-07 Boehringer Ingelheim Pharmaceuticals Inc. Compounds useful as reversible inhibitors of cysteine proteases
SI1482924T1 (sl) * 2002-03-05 2008-12-31 Merck Frosst Canada Ltd Katepsin cistein proteazni inhibitorji
DE60232547D1 (de) * 2002-03-11 2009-07-16 Kao Corp Kosmetika

Similar Documents

Publication Publication Date Title
JP2008513472A5 (enExample)
CY2020012I2 (el) Προφαρμακα των ενωσεων 2,4-πυριμιδινδιαμινης και οι χρησεις αυτων
JP2008506632A5 (enExample)
JP2009524695A5 (enExample)
WO2007048064A3 (en) Amino-pyrimidines as casein kinase ii (ck2) modulators
WO2006058700A8 (en) Acetamide compounds as fungicides
EP1938155A4 (en) BUSINESS PROCESS EXECUTE ENGINE
EP1794167A4 (en) SUBSTITUTED ISOXAZOLE AS FUNGICIDES
JP2007519721A5 (enExample)
WO2009064374A3 (en) Oral formulations of bis(thiohydrazide amides)
JP2007520565A5 (enExample)
ATE531717T1 (de) Neue kristalline form eines pyridazinoä4,5- büindolderivats
DE602005000415D1 (de) Tintenstrahl-Aufzeichnungsblatt
EP1945731A4 (en) ADHESIVE AGENTS
ZA200707933B (en) Substituted aryl 1.4-pyrazine derivatives
ITTO20060517A1 (it) "passante per alloggiamento"
JP2009215399A5 (enExample)
ATE533756T1 (de) N-formyl-hydroxylamin-verbindungen
BRPI0812460A2 (pt) " compostos orgânicos ".
BRPI0610156A2 (pt) forma micronizada de um composto, forma purificada i do composto, kit, padrão de referência, e, método de preparaçao de uma composição farmacêutica.
JP2007508806A5 (enExample)
JP2005298393A5 (enExample)
JP2005298653A5 (enExample)
JP2006516578A5 (enExample)
JP2010504415A5 (enExample)